RedSail Technologies® is pleased to announce an exciting partnership with InfiniTrak, a leading provider of track and trace compliance solutions, to deliver a fully integrated Drug Supply Chain Security Act (DSCSA) solution to the esteemed RedSail network of pharmacies. InfiniTrak was created with the dispenser in mind, utilizing user-friendly solutions that automate and improve functionality, which easily integrate into pharmacy operations and systems. For more information, visit infinitrak.us.
Important Notice: Firmware Unavailable for GX430t Printers
QS/1 is unable to offer firmware for GX430t printers if customers purchase them from other sources. Zebra has ceased providing us with licenses, leaving us unable to sell them to customers. Unfortunately, there are still customers who are purchasing GX430t printers from third parties, only to find that they lack the necessary firmware. If you require a label printer, please email our Upgrades department at upgrades@redsailtechnologies.com to purchase the Zebra ZD621 model.
Hardware Maintenance Ending for Select Okidata Printers
Some customers have one or more Okidata printers covered under their Hardware Maintenance Agreement that have reached end of life. As of July 17, 2023, RedSail Technologies can no longer support replacements or repairs for these printers because we cannot acquire replacement printers or parts. 
Okidata ML321P Dot Matrix Printer
Stock Number: H-ML321P
Okidata ML590P Dot Matrix Printer
Stock Number: H-ML590P
Okidata ML591P Dot Matrix Printer
Stock Number: H-ML591P
Okidata ML395P Dot Matrix Printer
Stock Number: H-ML395P
Okidata ML320T Dot Matrix Printer
Stock Number: H-ML320T
Okidata ML321T Dot Matrix Printer
Stock Number: H-ML321T
Okidata ML420 Dot Matrix Printer
Stock Number: H-91909701
Okidata ML421 Dot Matrix Printer
Stock Number: H-92009701
Because we’re discontinuing hardware maintenance on these older models, we’re offering a limited-time printer promotion with significantly reduced pricing and free on-site installation.
Exciting news! The FDA has approved the first vaccine for Respiratory Syncytial Virus (RSV). This breakthrough in respiratory health is a significant step in protecting our most vulnerable population: older adults. Arexvy is approved for the prevention of RSV in individuals 60 years of age and older.
The Drug Enforcement Administration (DEA) recently issued a temporary rule extending telehealth for prescribing controlled substances. This rule marks an important step towards accessible healthcare and patient-centric services. By embracing telehealth platforms, patients can now benefit from the convenience and safety of remote consultations while still receiving the necessary prescriptions for controlled substances. As technology advances and healthcare practices evolve, the DEA's decision to expand telehealth services displays a commitment to innovative solutions that prioritize patient well-being and equitable access to medication.
PrimeCare® customers, Miriam Cho, PharmD, President/CPO of MAC Rx, joined Integra X Files hosts for an inspiring conversation about pharmacy automation and how an automation strategy can enable operational growth, support staff, and provide better care for patients. Spoiler alert: You have to name the robots!
